Medivie Therapeutic Ltd Market Cap ($347.09K)
Market Cap & Net Worth: Medivie Therapeutic Ltd (MDVI)
Medivie Therapeutic Ltd market cap. Medivie Therapeutic Ltd (TA:MDVI) has a market capitalization of $347.09K (ILA129.46 Million) as of November 8, 2026. Listed on the TA stock exchange, this Israel-based company holds position #31189 globally and #458 in its home market, demonstrating a -5.86% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Medivie Therapeutic Ltd's stock price ILA45.00 by its total outstanding shares 2876970 (2.88 Million). Also see MDVI cash flow conversion for how efficiently the company converts equity into cash flow.
Medivie Therapeutic Ltd Market Cap History (2015–2026)
Medivie Therapeutic Ltd market cap history from 2015 to 2026. Data shows change from $64.02 Million to $347.09K (-51.48% CAGR). Check Medivie Therapeutic Ltd (MDVI) stock price for real-time trading data and today's change.
Medivie Therapeutic Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Medivie Therapeutic Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore MDVI shareholders equity momentum to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
13.02x
Medivie Therapeutic Ltd's market cap is 13.02 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $64.02 Million | $159.00K | -$4.33 Million | 402.63x | N/A |
| 2016 | $11.11 Million | $258.00K | -$4.74 Million | 43.05x | N/A |
| 2017 | $20.43 Million | $196.00K | -$4.45 Million | 104.24x | N/A |
| 2019 | $6.64 Million | $486.00K | -$11.58 Million | 13.67x | N/A |
| 2020 | $6.39 Million | $491.00K | -$6.59 Million | 13.02x | N/A |
Competitor Companies of MDVI by Market Capitalization
Companies near Medivie Therapeutic Ltd in the global market cap rankings as of November 8, 2026. Also see MDVI asset base for a full breakdown of the balance sheet.
Key companies related to Medivie Therapeutic Ltd by market ranking:
- SPG Co. Ltd (KQ:058610): Ranked #8421 globally with a market cap of $1.04 Billion USD ( ₩1.54 Trillion KRW).
- BHI Co. Ltd (KQ:083650): Ranked #10923 globally with a market cap of $606.39 Million USD ( ₩894.79 Billion KRW).
- Woori Technology Inc (KQ:032820): Ranked #11873 globally with a market cap of $500.95 Million USD ( ₩739.21 Billion KRW).
- Sungho Electronics Corp (KQ:043260): Ranked #12514 globally with a market cap of $443.17 Million USD ( ₩653.94 Billion KRW).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #8421 | SPG Co. Ltd | KQ:058610 | $1.04 Billion | ₩73600.00 |
| #10923 | BHI Co. Ltd | KQ:083650 | $606.39 Million | ₩35000.00 |
| #11873 | Woori Technology Inc | KQ:032820 | $500.95 Million | ₩7730.00 |
| #12514 | Sungho Electronics Corp | KQ:043260 | $443.17 Million | ₩18730.00 |
Market Capitalization of Medivie Therapeutic Ltd (2015–2026)
Market capitalization of Medivie Therapeutic Ltd from 2015 to today. Between 2015 and today, Medivie Therapeutic Ltd's market cap moved from $64.02 Million to $ 347.09K, with a yearly change of -51.48%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | ILA347.09K | -15.73% |
| 2025 | ILA411.88K | +53.89% |
| 2024 | ILA267.64K | -52.14% |
| 2023 | ILA559.20K | -29.95% |
| 2022 | ILA798.30K | -87.24% |
| 2021 | ILA6.26 Million | -2.14% |
| 2020 | ILA6.39 Million | -3.75% |
| 2019 | ILA6.64 Million | -78.52% |
| 2018 | ILA30.92 Million | +51.34% |
| 2017 | ILA20.43 Million | +83.96% |
| 2016 | ILA11.11 Million | -82.65% |
| 2015 | ILA64.02 Million | -- |
End of Day Market Cap According to Different Sources
On Nov 7th, 2026 the market cap of Medivie Therapeutic Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $347.09K USD |
| MoneyControl | $347.09K USD |
| MarketWatch | $347.09K USD |
| marketcap.company | $347.09K USD |
| Reuters | $347.09K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Medivie Therapeutic Ltd
Medivie Therapeutic Limited develops and markets dental devices. It offers Laboraide, a dental device that is placed between the woman's lower and upper jaw during birth, which allows the relaxation of the jaw, neck, and head muscles through the flow of oxygen to the muscles. The company also develops modular pacifiers that enables development of mouth structure and prevent future damage to the c… Read more